Available Until 10/27/2023

New Paradigms for Migraine Treatment and Prevention

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACPE Activity Number: 0204-0000-20-035-H01-P
Release Date: October 27, 2020
Expiration Date: October 27, 2023
Activity Type: 
CE Credits: 1.0 hour, no partial credit
Activity Fee: Members – Free / Non-Member – Not Available  

 This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview

Direct-to-consumer advertising has increased patient awareness and is driving more patients to seek information and treatment for migraine headaches. Oral medications, such as propranolol, topiramate, and sodium valproate, are most frequently used first line for prevention of migraine headaches, based on current guidelines, cost and ease of use. Both patients and prescribers will look to pharmacists for their knowledge and expertise to assist in assessing cost versus benefit of these new medications. The pharmacist also has a role in migraine clinics which can help patients manage their symptoms and lead a productive life when their medications are monitored and adjusted for their needs. This activity will discuss the pharmacists role in migraine treatment and medication management.


The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This activity was planned to meet the educational needs of pharmacists involved in formulary decision making and pharmacists that are involved in team-based care of patients with migraine headaches.

Learning Objectives

  • Summarize current treatment guidelines for migraine headache treatment and prevention.
  • List therapeutic strategies for managing migraine.
  • Identify the new oral medications FDA-approved for the management of acute migraine attacks.
  • Describe the places in migraine therapy that newly approved medications can be used for the management and treatment of migraine.

Schedule of Activities

  • Introduction and Announcements
  • Presentation
  • Questions, Answers, and Discussion


  • Kelsey H. Blom, Pharm.D., BCACP, Clinical Pharmacy Specialist - Neurology, Kaiser Permanente. Portland, OR
  • Deanna Moretz, Pharm.D., BCPS, Clinical Pharmacy Specialist, Oregon State University College of Pharmacy. Portland, OR
  • Elizabeth Shlom, Pharm.D., BCPS, SVP and Director, Clinical Pharmacy Services, Acurity, Inc. New York, NY


In accordance with the ACPE's and ACCME's Standards for Commercial Support, anyone in a position to control the content of an educational activity is required to disclose to the accredited provider their relevant financial relationships. In accordance with these Standards, all potential conflicts of interest have been resolved. An individual has a relevant financial relationship if he or she (or spouse/domestic partner) has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the activity content over which the individual has control.

As defined by ACCME, a commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The Standards for Commercial Support do not consider providers of clinical service directly to patients to be commercial interests. The existence or non-existence of relevant financial relationships will be disclosed to the activity audience. All identified conflicts of interest must be resolved prior to the activity.

  • All planners, presenters, reviewers, and ASHP staff report no financial relationships relevant to this activity.

Methods and CE Requirements

This activity consists of a recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP eLearning Portal. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Claim your CE at http://elearning.ashp.org. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.